<http://schema.org/description>
"Cardiome will regain global marketing and development rights for the intravenous as well as the oral formulations of vernakalant from Merck."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/83999/merck-to-return-vernakalant-rights>